Private Credit Series – Issue No. 1 Credit Assessment Scorecards
This article is the first in a Private Credit Series by S&P Global, focusing on unsolicited credit risk assessment for public corporates using internal scorecards. It specifically targets mid-market companies crucial to the private credit ecosystem. The initial assessment is presented for BioCryst Pharma Inc. (NasdaqGS:BCRX), a biotechnology company, to provide insights into the financial health of corporate borrowers in the private credit industry.
https://www.spglobal.com/market-intelligence/en/news-insights/resources/privatecredit-credit-assessment-scorecards